Purchase Order 75N98026P01121

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for the QiaCube Connect System and accessories, valued at $30,022.00, on June 18, 2020. Performance is located in Germantown, Maryland. The order carries firm fixed price terms and is scheduled for completion by September 30, 2020. The awardee is a foreign-owned manufacturer specializing in molecular diagnostics, scientific equipment, and bioinformatics solutions.</p>

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $25,000 purchase order to Qiagen, LLC for QIACUBE CONNECT MDX DEVICE PRV-1. The contract has a period of performance from December 28, 2023 through January 26, 2024 and utilizes firm fixed pricing. Qiagen will provide medical devices to the NIH Clinical Center in Germantown, Maryland to support the Center's biomedical research programs. No subcontractors or set aside designations were...

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Qiagen, LLC for $13,936.20 in QIAcube-compatible QIAseq sequencing kits on September 13, 2021, with ultimate completion on July 7, 2022. The order was issued to de-obligate unexpiring fiscal year 2021 funds in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 period-of-availability close. Performance takes place in Germantown, Maryland. The purchase order carries firm fixed price pricing...

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>

This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC for $28,440.75. The contract is for the QIAGEN QIAcube HT/QIAxtractor System, which are sample and assay technologies used to support federal agencies' biomedical research, public health, and healthcare programs. Qiagen, LLC is a subsidiary of the multinational biotechnology company...

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC valued at $6,021.00 on August 22, 2017 for service agreements supporting QIAxcel and QIACube instruments. Performance is at Bethesda, Maryland. The purchase order provides maintenance and support services to ensure continued availability of these sample preparation and analysis instruments. Performance concludes on September 20, 2018.</p>

This firm-fixed-price purchase order for $24,995.00 was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the QUICUBE CONNECT MDX THROUGH THE TRADE-IN &amp; TRADE-UP, with a completion date of December 26, 2024. Qiagen is an experienced federal contractor, providing a range of products and services to support the biomedical...

<p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>

<p>The NIH Clinical Center issued a purchase order to Qiagen, LLC on June 12, 2018 for $7,808.68 with firm fixed-price pricing and an ultimate completion date of June 20, 2018. Performance is at Bethesda, Maryland. The source does not specify what is being purchased.</p>

The NIH Clinical Center awarded a purchase order to Qiagen, LLC on June 13, 2018, with a ceiling value of $216,766.82 for firm fixed-price delivery of QIAGEN products and services. The order's ultimate completion date was December 31, 2020. Place of performance is Valencia, California. This purchase order is now being administratively de-obligated to close unexpended fiscal year 2021 funding in preparation for the September 30, 2026 period-of-availability closing, in accordance with 31 U.S.C....